Provided by Tiger Trade Technology Pte. Ltd.

CareDx

19.49
+0.13000.67%
Post-market: 19.490.00000.00%17:38 EST
Volume:461.77K
Turnover:9.04M
Market Cap:1.00B
PE:16.04
High:19.91
Open:19.41
Low:19.36
Close:19.36
52wk High:25.95
52wk Low:10.96
Shares:51.43M
Float Shares:51.43M
Volume Ratio:0.44
T/O Rate:0.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.22
EPS(LYR):0.9958
ROE:24.11%
ROA:-4.01%
PB:3.22
PE(LYR):19.57

Loading ...

Stock Track | CareDx Stock Soars 15.36% After Hours on Strong Q3 Earnings Beat

Stock Track
·
Nov 05

Stock Track | CareDx Shares Soar 15.36% After-Hours on Strong Q3 Earnings Beat

Stock Track
·
Nov 05

CareDx Reports Q3 Revenue of $100.1 Million and Net Income of $1.7 Million

Reuters
·
Nov 05

CareDx Outlook FY Revenue USD 372-376 Million

THOMSON REUTERS
·
Nov 05

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 04

Truth Social to Become World’s First Social Media Platform Offering Prediction Markets via Exclusive Partnership with Crypto.com

GlobeNewswire
·
Oct 28

CareDx appoints Jeffrey Teuteberg as chief medical officer

TIPRANKS
·
Oct 27

CareDx Announces Appointment of Jeffrey John Teuteberg, Md as Chief Medical Officer

THOMSON REUTERS
·
Oct 27

CareDx Appoints Suresh Gunasekaran as New Director

TIPRANKS
·
Oct 25

CareDx Inc. Files Initial Statement of Beneficial Ownership for Director Suresh Gunasekaran

Reuters
·
Oct 25

CareDx Study Validates AlloSure Heart as Reliable Biomarker for Heart Transplant Rejection

Reuters
·
Oct 24

Caredx Announces Appointment Of Suresh Gunasekaran To Board Of Directors

Reuters
·
Oct 23

CareDx Appoints Suresh Gunasekaran to Board of Directors

Reuters
·
Oct 23

CareDx Announces Appointment of Suresh Gunasekaran to Board of Directors

THOMSON REUTERS
·
Oct 23

CareDx Inc. to Release Third Quarter 2025 Financial Results

Reuters
·
Oct 21

CareDx Inc. Secures IVDR Certification for AlloSeq® Tx and QTYPE® HLA Typing Products in European Union, Reinforcing Global Transplant Diagnostics Leadership

Reuters
·
Oct 06

CareDx Announces New Ivd Products and Ivdr Certification for Alloseq® Tx and Qtype® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting

THOMSON REUTERS
·
Oct 06

CareDx Price Target Maintained With a $22.00/Share by BTIG

Dow Jones
·
Sep 23

CareDx Price Target Maintained With a $22.00/Share by BTIG

Dow Jones
·
Sep 12

CareDx- Submits Comment Letter on Draft Lcd for Molecular Testing for Solid Organ Transplant Rejection

THOMSON REUTERS
·
Sep 03